Gyre Therapeutics (NASDAQ:GYRE) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen lowered shares of Gyre Therapeutics (NASDAQ:GYRE – Free Report) from a buy rating to a hold rating in a research report released on Saturday. GYRE has been the topic of several other reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Gyre Therapeutics in a research report on Thursday, January […]
15 Mar 03:25 · The Cerbat Gem